Literature DB >> 16678779

SynMuv genes redundantly inhibit lin-3/EGF expression to prevent inappropriate vulval induction in C. elegans.

Mingxue Cui1, Jun Chen, Toshia R Myers, Byung Joon Hwang, Paul W Sternberg, Iva Greenwald, Min Han.   

Abstract

Activation of EGFR-Ras-MAPK signaling in vulval precursor cells (VPCs) by LIN-3/EGF from the gonad induces vulval development in C. elegans. The prevailing view is that LIN-3 overcomes an "inhibitory signal" from the adjacent hyp7 hypodermal syncytium. This view originated from observations indicating that inactivation of functionally redundant Synthetic Multivulva (SynMuv) genes in hyp7 can activate EGFR-Ras-MAPK signaling in the VPCs. Many SynMuv genes encode transcription and chromatin-associated factors, including the Rb ortholog. Here, we show that the SynMuv A and SynMuv B gene classes are functionally redundant for transcriptional repression of the key target gene, lin-3/EGF, in the hypodermis. These observations necessitate a revision of the concept of "inhibitory signaling." They also underscore the importance of preventing inappropriate cell signaling during development and suggest that derepression of growth factors may be the mechanism by which tumor suppressor genes such as Rb can have cell nonautonomous effects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16678779     DOI: 10.1016/j.devcel.2006.04.001

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  66 in total

Review 1.  Cancer models in Caenorhabditis elegans.

Authors:  Natalia V Kirienko; Kumaran Mani; David S Fay
Journal:  Dev Dyn       Date:  2010-05       Impact factor: 3.780

2.  Identification and classification of genes that act antagonistically to let-60 Ras signaling in Caenorhabditis elegans vulval development.

Authors:  Craig J Ceol; Frank Stegmeier; Melissa M Harrison; H Robert Horvitz
Journal:  Genetics       Date:  2006-04-19       Impact factor: 4.562

Review 3.  The SynMuv genes of Caenorhabditis elegans in vulval development and beyond.

Authors:  David S Fay; John Yochem
Journal:  Dev Biol       Date:  2007-03-20       Impact factor: 3.582

4.  The Caenorhabditis elegans CDT-2 ubiquitin ligase is required for attenuation of EGFR signalling in vulva precursor cells.

Authors:  Gino B Poulin; Julie Ahringer
Journal:  BMC Dev Biol       Date:  2010-10-26       Impact factor: 1.978

5.  PHA-4/FoxA cooperates with TAM-1/TRIM to regulate cell fate restriction in the C. elegans foregut.

Authors:  Julie C Kiefer; Pliny A Smith; Susan E Mango
Journal:  Dev Biol       Date:  2006-12-02       Impact factor: 3.582

6.  The Caenorhabditis elegans ekl (enhancer of ksr-1 lethality) genes include putative components of a germline small RNA pathway.

Authors:  Christian E Rocheleau; Kevin Cullison; Kai Huang; Yelena Bernstein; Annina C Spilker; Meera V Sundaram
Journal:  Genetics       Date:  2008-02-03       Impact factor: 4.562

7.  RNA interference and retinoblastoma-related genes are required for repression of endogenous siRNA targets in Caenorhabditis elegans.

Authors:  Alla Grishok; Sebastian Hoersch; Phillip A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-10       Impact factor: 11.205

8.  Implicating SCF complexes in organogenesis in Caenorhabditis elegans.

Authors:  Stanley R G Polley; Aleksandra Kuzmanov; Jujiao Kuang; Jonathan Karpel; Vladimir Lažetić; Evguenia I Karina; Bethany L Veo; David S Fay
Journal:  Genetics       Date:  2013-11-08       Impact factor: 4.562

9.  lin-35/Rb and the CoREST ortholog spr-1 coordinately regulate vulval morphogenesis and gonad development in C. elegans.

Authors:  Aaron M Bender; Natalia V Kirienko; Sara K Olson; Jeffery D Esko; David S Fay
Journal:  Dev Biol       Date:  2006-10-05       Impact factor: 3.582

Review 10.  The Caenorhabditis elegans epidermis as a model skin. I: development, patterning, and growth.

Authors:  Andrew D Chisholm; Tiffany I Hsiao
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2012-06-19       Impact factor: 5.814

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.